Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INTUITIVE SURGICAL INC Director's Dealing 2023

Apr 25, 2023

29809_dirs_2023-04-24_95a5b107-0ecd-48ce-b33e-414615d86e1b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INTUITIVE SURGICAL INC (ISRG)
CIK: 0001035267
Period of Report: 2023-04-21

Reporting Person: RUBASH MARK J (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-04-21 Common Stock M 463 $90.4944 Acquired 15463 Direct
2023-04-21 Common Stock S 463 $297.8943 Disposed 15000 Direct
2023-04-21 Common Stock M 173 $71.3233 Acquired 15173 Direct
2023-04-21 Common Stock S 173 $297.8943 Disposed 15000 Direct
2023-04-21 Common Stock M 349 $71.3233 Acquired 15349 Direct
2023-04-21 Common Stock S 349 $297.9281 Disposed 15000 Direct
2023-04-21 Common Stock M 349 $71.3233 Acquired 15349 Direct
2023-04-21 Common Stock S 349 $297.9443 Disposed 15000 Direct
2023-04-21 Common Stock M 349 $71.3233 Acquired 15349 Direct
2023-04-21 Common Stock S 349 $297.9402 Disposed 15000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-04-21 Non-Qualified Stock Option (right to buy) $71.3233 M 173 Disposed 2026-04-21 Common Stock (173) Direct
2023-04-21 Non-Qualified Stock Option (right to buy) $71.3233 M 349 Disposed 2026-04-21 Common Stock (349) Direct
2023-04-21 Non-Qualified Stock Option (right to buy) $71.3233 M 349 Disposed 2026-04-21 Common Stock (349) Direct
2023-04-21 Non-Qualified Stock Option (right to buy) $71.3233 M 349 Disposed 2026-04-21 Common Stock (349) Direct
2023-04-21 Non-Qualified Stock Option (right to buy) $90.4944 M 927 Disposed 2027-04-20 Common Stock (927) Direct
2023-04-21 Non-Qualified Stock Option (right to buy) $90.4944 M 927 Disposed 2027-04-20 Common Stock (927) Direct
2023-04-21 Non-Qualified Stock Option (right to buy) $90.4944 M 927 Disposed 2027-04-20 Common Stock (927) Direct
2023-04-21 Non-Qualified Stock Option (right to buy) $90.4944 M 463 Disposed 2027-04-20 Common Stock (463) Direct
2023-04-21 Non-Qualified Stock Option (right to buy) $154.2367 M 598 Disposed 2028-04-19 Common Stock (598) Direct
2023-04-21 Non-Qualified Stock Option (right to buy) $154.2367 M 598 Disposed 2028-04-19 Common Stock (598) Direct
2023-04-21 Non-Qualified Stock Option (right to buy) $154.2367 M 598 Disposed 2028-04-19 Common Stock (598) Direct
2023-04-21 Non-Qualified Stock Option (right to buy) $154.2367 M 299 Disposed 2028-04-19 Common Stock (299) Direct
2023-04-21 Non-Qualified Stock Option (right to buy) $171.0733 M 460 Disposed 2030-04-23 Common Stock (460) Direct
2023-04-21 Non-Qualified Stock Option (right to buy) $171.0733 M 460 Disposed 2030-04-23 Common Stock (460) Direct
2023-04-21 Non-Qualified Stock Option (right to buy) $171.0733 M 460 Disposed 2030-04-23 Common Stock (460) Direct
2023-04-21 Non-Qualified Stock Option (right to buy) $171.0733 M 230 Disposed 2030-04-23 Common Stock (230) Direct
2023-04-21 Non-Qualified Stock Option (right to buy) $172.5933 M 472 Disposed 2029-04-25 Common Stock (472) Direct
2023-04-21 Non-Qualified Stock Option (right to buy) $172.5933 M 472 Disposed 2029-04-25 Common Stock (472) Direct
2023-04-21 Non-Qualified Stock Option (right to buy) $172.5933 M 472 Disposed 2029-04-25 Common Stock (472) Direct
2023-04-21 Non-Qualified Stock Option (right to buy) $172.5933 M 235 Disposed 2029-04-25 Common Stock (235) Direct

Footnotes

F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 1, 2024.

F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.45 to $299.15 as follows: 275 shares sold at $296.45 to $297.41; 888 shares sold at $297.48 to $298.48; and 237 shares sold at $298.50 to $299.15. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F3: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.62 to $299.27 as follows: 638 shares sold at $296.62 to $297.49; 1,718 shares sold at $297.68 to $298.67; and 450 shares sold at $298.69 to $299.27. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F4: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.60 to $299.28 as follows: 638 shares sold at $296.60 to $297.51; 1,768 shares sold at $297.72 to $298.69; and 400 shares sold at $298.74 to $299.28. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F5: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.60 to $299.27 as follows: 638 shares sold at $296.60 to $297.49; 1,768 shares sold at $297.73 to $298.69; and 400 shares sold at $298.74 to $299.27. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F6: 100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting
Person's continued service as a director to the issuer.

F7: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company.